Biocompatibility assessment of silk nanoparticles

hemocompatibility and internalization by human blood cells

Manfred F. Maitz, Claudia Sperling, Thidarat Wongpinyochit, Manuela Herklotz, Carsten Werner, F. Philipp Seib

Research output: Contribution to journalArticle

17 Citations (Scopus)
77 Downloads (Pure)

Abstract

Many nanoparticles are designed for use as potential nanomedicines for parenteral administration. However, emerging evidence suggests that hemocompatibility is important, but is highly particle- and test-bed dependent. Thus, knowledge of bulk material properties does not predict the hemocompatibility of uncharacterized nanoparticles, including silk nanoparticles. This study compares the hemocompatibility of silk versus silica nanoparticles, using whole human blood under quasi-static and flow conditions. Substantial hemocompatibility differences are noted for some nanoparticles in quasi-static versus dynamic studies; i.e., the inflammatory response to silk nanoparticles is significantly lower under flow versus quasi-static conditions. Silk nanoparticles also have very low coagulant properties - an observation that scales from the macro- to the nano-level. These nanoparticle hemocompatibility studies are complemented by preliminary live cell measurements to evaluate the endocytosis and trafficking of nanoparticles in human blood cells. Overall, this study demonstrates that nanoparticle hemocompatibility is affected by several factors, including the test bed design.
Original languageEnglish
Pages (from-to)2633-2642
Number of pages10
JournalNanomedicine: Nanotechnology, Biology and Medicine
Volume13
Issue number8
Early online date27 Jul 2017
DOIs
Publication statusPublished - 30 Nov 2017

Fingerprint

Silk
Biocompatibility
Nanoparticles
Blood Cells
Blood
Cells
Nanomedicine
Medical nanotechnology
Coagulants
Endocytosis
Silicon Dioxide
Macros
Materials properties
Silica
Observation

Keywords

  • silk
  • fibroin
  • silica
  • blood compatibility
  • nanoparticles
  • nanomedicine

Cite this

@article{876cbbe5c9604369932d16e0c82b054c,
title = "Biocompatibility assessment of silk nanoparticles: hemocompatibility and internalization by human blood cells",
abstract = "Many nanoparticles are designed for use as potential nanomedicines for parenteral administration. However, emerging evidence suggests that hemocompatibility is important, but is highly particle- and test-bed dependent. Thus, knowledge of bulk material properties does not predict the hemocompatibility of uncharacterized nanoparticles, including silk nanoparticles. This study compares the hemocompatibility of silk versus silica nanoparticles, using whole human blood under quasi-static and flow conditions. Substantial hemocompatibility differences are noted for some nanoparticles in quasi-static versus dynamic studies; i.e., the inflammatory response to silk nanoparticles is significantly lower under flow versus quasi-static conditions. Silk nanoparticles also have very low coagulant properties - an observation that scales from the macro- to the nano-level. These nanoparticle hemocompatibility studies are complemented by preliminary live cell measurements to evaluate the endocytosis and trafficking of nanoparticles in human blood cells. Overall, this study demonstrates that nanoparticle hemocompatibility is affected by several factors, including the test bed design.",
keywords = "silk, fibroin, silica, blood compatibility, nanoparticles, nanomedicine",
author = "Maitz, {Manfred F.} and Claudia Sperling and Thidarat Wongpinyochit and Manuela Herklotz and Carsten Werner and Seib, {F. Philipp}",
year = "2017",
month = "11",
day = "30",
doi = "10.1016/j.nano.2017.07.012",
language = "English",
volume = "13",
pages = "2633--2642",
journal = "Nanomedicine: Nanotechnology, Biology and Medicine",
issn = "1549-9634",
number = "8",

}

Biocompatibility assessment of silk nanoparticles : hemocompatibility and internalization by human blood cells. / Maitz, Manfred F.; Sperling, Claudia; Wongpinyochit, Thidarat; Herklotz, Manuela; Werner, Carsten; Seib, F. Philipp.

In: Nanomedicine: Nanotechnology, Biology and Medicine, Vol. 13, No. 8, 30.11.2017, p. 2633-2642.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Biocompatibility assessment of silk nanoparticles

T2 - hemocompatibility and internalization by human blood cells

AU - Maitz, Manfred F.

AU - Sperling, Claudia

AU - Wongpinyochit, Thidarat

AU - Herklotz, Manuela

AU - Werner, Carsten

AU - Seib, F. Philipp

PY - 2017/11/30

Y1 - 2017/11/30

N2 - Many nanoparticles are designed for use as potential nanomedicines for parenteral administration. However, emerging evidence suggests that hemocompatibility is important, but is highly particle- and test-bed dependent. Thus, knowledge of bulk material properties does not predict the hemocompatibility of uncharacterized nanoparticles, including silk nanoparticles. This study compares the hemocompatibility of silk versus silica nanoparticles, using whole human blood under quasi-static and flow conditions. Substantial hemocompatibility differences are noted for some nanoparticles in quasi-static versus dynamic studies; i.e., the inflammatory response to silk nanoparticles is significantly lower under flow versus quasi-static conditions. Silk nanoparticles also have very low coagulant properties - an observation that scales from the macro- to the nano-level. These nanoparticle hemocompatibility studies are complemented by preliminary live cell measurements to evaluate the endocytosis and trafficking of nanoparticles in human blood cells. Overall, this study demonstrates that nanoparticle hemocompatibility is affected by several factors, including the test bed design.

AB - Many nanoparticles are designed for use as potential nanomedicines for parenteral administration. However, emerging evidence suggests that hemocompatibility is important, but is highly particle- and test-bed dependent. Thus, knowledge of bulk material properties does not predict the hemocompatibility of uncharacterized nanoparticles, including silk nanoparticles. This study compares the hemocompatibility of silk versus silica nanoparticles, using whole human blood under quasi-static and flow conditions. Substantial hemocompatibility differences are noted for some nanoparticles in quasi-static versus dynamic studies; i.e., the inflammatory response to silk nanoparticles is significantly lower under flow versus quasi-static conditions. Silk nanoparticles also have very low coagulant properties - an observation that scales from the macro- to the nano-level. These nanoparticle hemocompatibility studies are complemented by preliminary live cell measurements to evaluate the endocytosis and trafficking of nanoparticles in human blood cells. Overall, this study demonstrates that nanoparticle hemocompatibility is affected by several factors, including the test bed design.

KW - silk

KW - fibroin

KW - silica

KW - blood compatibility

KW - nanoparticles

KW - nanomedicine

UR - http://www.sciencedirect.com/science/journal/15499634

U2 - 10.1016/j.nano.2017.07.012

DO - 10.1016/j.nano.2017.07.012

M3 - Article

VL - 13

SP - 2633

EP - 2642

JO - Nanomedicine: Nanotechnology, Biology and Medicine

JF - Nanomedicine: Nanotechnology, Biology and Medicine

SN - 1549-9634

IS - 8

ER -